Didik SetiawanMonika Puri OktoraRaymond HutubessyArthorn RiewpaiboonMaarten J. PostmaUniversity of GroningenUniversitas Muhammadiyah PurwokertoOrganisation Mondiale de la SantéMahidol UniversityUniversity of Groningen, University Medical Center Groningen2018-12-212019-03-142018-12-212019-03-142017-09-02Expert Review of Vaccines. Vol.16, No.9 (2017), 933-94317448395147605842-s2.0-85028584313https://repository.li.mahidol.ac.th/handle/20.500.14594/41818© 2017 Informa UK Limited, trading as Taylor & Francis Group. Introduction: The cervical cancer-related burden is an important problem in Southeast Asian (SEA) countries. However, only 3 out of 11 countries implement the comprehensive prevention program. Areas covered: This is a retrospective review from all relevant studies until 2015 from two main databases, MEDLINE/Pubmed and Embase in order to provide an evidence on the health economics of HPV vaccination in the region. Expert commentary: The implementation of HPV vaccination will generate substantial health and economic benefit in SEA countries since the number of cervical cancer cases in this region are generally high. Therefore, a clear recommendation on how HPV vaccination should be implemented in a country, for example on how many doses will be used, how much cost is required or is it a school based- or clinical based-delivery, is critically required.Mahidol UniversityBiochemistry, Genetics and Molecular BiologyImmunology and MicrobiologyReviewSCOPUS10.1080/14760584.2017.1357472